For all of the quality care it delivers, the U.S. health care system is one of the most dysfunctional sectors of the U.S. economy. The government spends nearly 50 cents of every dollar spent on health care, most consumers are almost entirely insulated from the cost of their decisions, and employers decide what kind of health insurance their employees get.
But while the U.S. health care system begs for reform, the Patient Protection and Affordable Care Act only exacerbates all of the current problems, promising to devolve into a price-controlled system rationed and micromanaged by bureaucrats.
IPI believes there are much better options: reform the tax treatment of health insurance; remove the state and federal mandates and regulations that make coverage more expensive; pass medical liability reform; and promote policies that create value-conscious shoppers in the health care marketplace.
Millennials' Health Insurance Premiums Skyrocket Under Obamacare
The cost of health insurance premiums for young, healthy Americans have increased significantly under Obamacare. Dr. Merrill Matthews explains why premiums are going up for younger people, and that much of the cost is hidden by federal subsidies, and it will likely only get worse as the [nation’s] population ages.
There's 'No Sugarcoating' Health Insurance Exchange Failures
There's no sugarcoating how badly many of the state Obamacare exchanges have failed, and the problems are only just beginning.
Health Care Costs Are Declining Because You Are Paying More
The growth in health care spending has slowed down and President Obama wants you to know his health care law gets the credit. Or maybe the blame, because one reason for that slowdown is that you are spending more out of your own pocket.
Drug R&D Costs: $1.7 Billion and Rising
The significant costs of developing new, life-saving drugs and treatments has reached over $1.7 billion per drug over a span of 10-12 years, due to the growing complexity of drugs, bureaucratic red tape and the short length of a drug’s patent life.
The High Cost of Inventing New Drugs--And of Not Inventing Them
The cost of developing new prescription drugs is very expensive—a process made even more expensive than it has to be because of excessive government restrictions and limited patent life. However, not developing new drugs can also be expensive, both in financial and human costs.
The High Cost Of Inventing New Drugs -- And Of Not Inventing Them
If the cost of creating new drugs is high, the cost of not having any new drugs is immeasurable.
The Prescription Drug Act Works Well, and the President Can't Stand It
In Washington, nothing fails like success and nothing succeeds like failure. Just look at how some elected officials defend the worst health care law and criticize the best.
Medicare's Becoming A Means-Tested Welfare Program, And That Could Be A Good Thing
Those fighting to keep Medicare from becoming a means-tested welfare program are losing the battle, but that might be the only way we’re ever going to get real Medicare reform.
More Americans Will Benefit If Obamacare Loses the Supreme Court Challenge
If King wins, several million people will lose their health insurance subsidies. But a win for Obamacare means that tens of millions of uninsured Americans will have to pay a penalty in the hundreds or thousands of dollars.
Supreme Court Challenge Could Incite Obama-Abbott Stand Off Over State Exchange
The U.S. Supreme Court will hear the second biggest legal challenge to Obamacare on Wednesday, and a victory for freedom will likely lead to significant political pressure on 37 states to cave to Obamacare pressure. Texas Governor Greg Abbott will be one of the targeted 37 governors.